drugset / Trial / NCT06285617

Short-Term Versus 6-Week Prednisone in The Treatment of Subacute Thyroiditis

NCT06285617

Phase 3 Unknown 600 enrolled Xinqiao Hospital of Chongqing
RandomizedParallel-groupOpen-labelTreatment

Summary

The goal of this clinical trial is to compare the efficacy and safety of short-term versus 6-week prednisone in the treatment of moderate-to-severe subacute thyroiditis. The main questions it aims to answer are: Does the short-term medication regimen reduce glucocorticoid side effects while achieving similar efficacy as the guideline treatment group? Patients with moderate-to-severe symptoms were randomly assigned to receive either 30 mg/day prednisone for 1 week, followed by 1 week of nonsteroidal anti-inflammatory drugs, or the conventional 6-week prednisone therapy in the control group.

Timeline

Start
2024-04-01
Primary completion
2025-01-31
Completion
2025-04-30

Publications

Drugs

EvaluationDrugModalityDoseRoute
Subject Celecoxib Other / unclassified 200 mg
Subject Prednisone Other / unclassified 30 mg

Indications